Search
Addressing drug challenges in health and humanitarian crises: Settings in need of care for a comprehensive drug use prevention in Nigeria
Bi-Monthly Webinar: ISSUP Nigeria Knowledge Update Series (Thirteenth Session)
ISSUP Nigeria would like to invite you to attend their next Bi-Monthly Webinar in the Knowledge Update Series. The Webinar topic will be Beyond Dependence: Alcohol-induced Disorders.
Learning Outcomes:
• Sensitization to the wide...
Treating co-occurring substance use and mental health disorders using tools from CBT
Presented by Jo Cassar (The Matilda Centre for Research in Mental Health and Substance Use, University of Sydney), by the end of this webinar, attendees will be able to:
- Recognise the importance of assessing for substance use when a...
کھانے کی خرابی اور اے او ڈی کا استعمال: ڈاکٹروں کو کیا جاننے کی ضرورت ہے
ایسوسی ایٹ پروفیسر سارہ میگوائر (ڈائریکٹر، انسائڈ آؤٹ انسٹی ٹیوٹ) کی طرف سے پیش کردہ اس ویبینار میں شرکت سے شرکاء سیکھیں گے:
- کھانے کی خرابی کی سب سے عام علامات کو کیسے پہچانیں؛
- کھانے کی خرابی کی مداخلت اور کارکن انہیں کیسے فراہم...
Kenya to include smoking cessation drugs as essential medicines
The Ministry of Health has been advised to add two non-nicotine drugs to Kenya’s Essential Medicines List, to help smokers quit tobacco and nicotine addiction.
The World Health Organization said the two drugs bring “a powerful shift in...
Multiple disadvantage and co-occurring substance use and mental health conditions.
Substance use and mental health needs are two of the primary concerns for many people experiencing multiple disadvantage. We know that people who experience both issues at the same time (also known as “co-occurring conditions” or “dual...
The impact of discrimination on substance use disorders among sexual minorities
This paper aimed to review the literature regarding the impact of discrimination on substance use disorders among Sexual Minorities, with a focus on alcohol, opioids, stimulants, polydrug use, chemsex, cannabis and tobacco, as well as...
The cardiovascular risks and benefits of quit smoking medicines
In this presentation, the speakers reported the results of a series of three population-based cohort studies relating to the use and effects of smoking cessation pharmacotherapies. The first of these studies provided evidence on how the...
Association of Prenatal Exposure to Maternal Drinking and Smoking With the Risk of Stillbirth
Abstract
Importance Prenatal smoking is a known modifiable risk factor for stillbirth; however, the contribution of prenatal drinking or the combination of smoking and drinking is uncertain.
Objective To examine whether prenatal...
نائجیریا کی یونیورسٹیوں میں نشے سے متعلق مطالعاتی پروگراموں کی توثیق: چیلنجز، مواقع، اور وکالت کی ضرورت
تعارف:
نائجیریا میں منشیات کے علاج کی خدمات تک رسائی کم ہے جس کی وجہ منشیات کے علاج کے عملے میں شدید کمی ہے۔ نائجیریا کی یونیورسٹیوں میں منشیات کی لت کے تربیتی پروگرام متعارف کروا کر افرادی قوت کی کمی کو دور کرنے کے منصوبے جاری ہیں۔ یہ...
New Psychoactive Substances (NPS) Webinar Series
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...
The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis
New Psychoactive Substances: Reading List
Project NEPTUNE training modules
In partnership with the Royal College of Psychiatrists, Project NEPTUNE has developed training modules to improve clinical practice in the management of harms resulting from the use of club drugs and novel psychoactive substances.
These...
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances
This document provides guidance on the clinical management of harms resulting from acute intoxication and from the harmful and dependent use of club drugs and Novel Psychoactive Substances (NPS).
This is an extensive and comprehensive...
Handbook of Novel Psychoactive Substances: What Clinicians Should Know about NPS
Handbook of Novel Psychoactive Substances (NPS) provides a comprehensive overview of the challenges that clinicians face when dealing with NPS and discusses how the profile of patients and their socio-demographic characteristics frame the...
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
In light of the recent emergence of Novel Psychoactive Substances (NPS) on a global scale, this book provides a timely analysis of the social and economic impact of the NPS phenomenon, and of the global policy and regulatory responses to it...
Emerging Trends in Drugs, Addictions, and Health
Emerging Trends in Drugs, Addictions, and Health is a new international journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addiction and associated health phenomena.
The Journal has a...
UNODC Early Warning Advisory on New Psychoactive Substances
The rapid emergence of a large number of New Psychoactive Substances on the global drug market poses a significant risk to public health and a challenge to drug policy. Often, little is known about the adverse health effects and social...
New psychoactive substances (NPS)
Overview
A new psychoactive substance (NPS) is defined as 'a new narcotic or psychotropic drug, in pure form or in preparation, that is not controlled by the United Nations drug conventions, but which may pose a public health threat...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member